2021
DOI: 10.17650/1994-4098-2020-16-3-37-45
|View full text |Cite
|
Sign up to set email alerts
|

CDK4/6 inhibitors in the treatment of metastatic breast cancer. Choosing optimal therapy for estrogen-receptor-positive HER2-negative metastatic breast cancer: analysis of doctors’ preferences (“Prometheus”) in Russia – first results of the survey

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 31 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?